AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
E129: Sam Altman plays chess with regulators, AI's "nuclear" potential, big pharma bundling & more
All-In with Chamath, Jason, Sacks & Friedberg
Amgen's $28 Billion Acquisition of Horizon Therapeutics
5min Snip
00:00
Summary
Transcript
Episode notes
Freiberg: I'm generally pretty negative on a lot of the comments, Lena Kahn's made and her positioning. She actually went after the PBM's. And if you really care about drug inflation and you follow dollars, the real culprits around this are the pharmacy benefit managers. Freiberg: It seems unfortunately for the FTC, every merger just gets contested for the sake of it being contested. But I don't think something like Amgen-Horizon is coming from all over the horizon because what I think will happen is that somebody in there understands where the price inflation comes from.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode